Critical Care Medicine Doctors in Rochester, NH - Medicare Status, Address, Contact

1 Critical Care Medicine doctors found. Showing 1 - 1

Dr. Amit Joglekar, M.D.,
Internal Medicine - Critical Care Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 21 Whitehall Rd, Suite 302, Rochester, NH 03867
Phone: 603-335-0909

News Archive

Electronic food vouchers provide refugee children with better health and nutrition

Electronic food vouchers provided young Rohingya children in Bangladeshi refugee camps with better health and nutrition than direct food assistance, according to new research led by Cornell University, in conjunction with the International Food Policy Research Institute.

Chronic infection with S. maltophilia bacterium may impact cystic fibrosis progression: Study

Exacerbations in cystic fibrosis (CF) may be linked to chronic infection with a bacterium called Stenotrophomonas maltophilia, which was previously thought to simply colonize the CF lung. The finding that chronic infection with S. maltophilia is independently linked with an increased risk of exacerbations gives clinicians and researchers a new potential measure of the health status of CF patients, as well as a new potential target in fighting their disease.

Hospital nurses who work longer than 12 hour shifts experience emotional exhaustion, job dissatisfaction

Research carried out by NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex has found that hospital nurses who work longer than 12 hour shifts have a higher risk of wanting to leave their job, are more dissatisfied and more likely to burnout in terms of emotional exhaustion.

Combination of antiviral drugs outperforms single-drug therapy in children with hepatitis C

Children with hepatitis C fare decidedly better with a supercharged combination of two antiviral drugs than with the usual and standard single-drug regimen, according to research led by investigators at the Johns Hopkins Children Center.

Infinity commences enrollment in IPI-493 Phase 1 clinical trial for advanced hematologic malignancies

Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.

Critical Care Medicine Doctors in Rochester, NH Accepting Medicare